These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 1361570)

  • 41. The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys.
    Andersen MB; Fuxe K; Werge T; Gerlach J
    Behav Pharmacol; 2002 Dec; 13(8):639-44. PubMed ID: 12478214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
    Ishibashi T; Horisawa T; Tokuda K; Ishiyama T; Ogasa M; Tagashira R; Matsumoto K; Nishikawa H; Ueda Y; Toma S; Oki H; Tanno N; Saji I; Ito A; Ohno Y; Nakamura M
    J Pharmacol Exp Ther; 2010 Jul; 334(1):171-81. PubMed ID: 20404009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist.
    Picard M; Morisset S; Cloix JF; Bizot JC; Guerin M; Beneteau V; Guillaumet G; Hevor TK
    Neuroscience; 2010 Sep; 169(3):1337-46. PubMed ID: 20580787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones.
    Jaen JC; Wise LD; Heffner TG; Pugsley TA; Meltzer LT
    J Med Chem; 1991 Jan; 34(1):248-56. PubMed ID: 1671416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine.
    Caprathe BW; Jaen JC; Wise LD; Heffner TG; Pugsley TA; Meltzer LT; Parvez M
    J Med Chem; 1991 Sep; 34(9):2736-46. PubMed ID: 1680195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo effects of pardoprunox (SLV308), a partial D₂/D₃ receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity.
    Bétry C; Etiévant A; Lambás-Señas L; McCreary AC; Haddjeri N
    Synapse; 2011 Oct; 65(10):1042-51. PubMed ID: 21446003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
    Svensson K; Ekman A; Piercey MF; Hoffmann WE; Lum JT; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):263-74. PubMed ID: 1683686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microdialysis study of striatal dopamine in MPTP-hemilesioned rats challenged with apomorphine and amphetamine.
    Dombrowski PA; Carvalho MC; Miyoshi E; Correia D; Bortolanza M; Dos Santos LM; Wietzikoski EC; Eckart MT; Schwarting RK; Brandão ML; Da Cunha C
    Behav Brain Res; 2010 Dec; 215(1):63-70. PubMed ID: 20600337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo.
    Millan MJ; Rivet JM; Audinot V; Gobert A; Lejeune F; Brocco M; Newman-Tancredi A; Maurel-Remy S; Bervoets K
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1418-27. PubMed ID: 7791116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine autoreceptor agonists as potential antipsychotics. 1. (Aminoalkoxy)anilines.
    Jaen JC; Wise LD; Heffner TG; Pugsley TA; Meltzer LT
    J Med Chem; 1988 Aug; 31(8):1621-5. PubMed ID: 2899647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
    Oshiro Y; Sato S; Kurahashi N; Tanaka T; Kikuchi T; Tottori K; Uwahodo Y; Nishi T
    J Med Chem; 1998 Feb; 41(5):658-67. PubMed ID: 9513593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects.
    Svensson K; Eriksson E; Carlsson A
    Neuropharmacology; 1993 Oct; 32(10):1037-45. PubMed ID: 7905192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE; Haubrich DR; Williams M
    Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blockade of dopamine receptors explains the lack of 5-HT stereotypy on treatment with the putative 5-HT1A agonist LY165163.
    Donohoe TP; Hutson PH; Curzon G
    Psychopharmacology (Berl); 1987; 93(1):82-6. PubMed ID: 2957721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers.
    Arnt J; Bøgesø KP; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Psychopharmacology (Berl); 1983; 81(3):199-207. PubMed ID: 6139838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lithium inhibition of norepinephrine and dopamine receptors.
    Flemenbaum A
    Biol Psychiatry; 1977 Aug; 12(4):563-72. PubMed ID: 560884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of presynaptic 5-HT
    Mombereau C; Arnt J; Mørk A
    Pharmacol Biochem Behav; 2017 Feb; 153():141-146. PubMed ID: 28057524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.